Adaptive Immunity to Francisella tularensis and Considerations for Vaccine Development.

about

Adaptive Immunity to Francisella tularensis and Considerations for Vaccine Development.

Item

http://www.wikidata.org/entity/Q52571082

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Adaptive Immunity to Francisella tularensis and Considerations for Vaccine Development.

@en

Adaptive Immunity to Francisella tularensis and Considerations for Vaccine Development.

@nl

type

Item

label

Adaptive Immunity to Francisella tularensis and Considerations for Vaccine Development.

@en

Adaptive Immunity to Francisella tularensis and Considerations for Vaccine Development.

@nl

prefLabel

Adaptive Immunity to Francisella tularensis and Considerations for Vaccine Development.

@en

Adaptive Immunity to Francisella tularensis and Considerations for Vaccine Development.

@nl

P1476

Adaptive Immunity to Francisella tularensis and Considerations for Vaccine Development

@en

P2093

Jeffrey A Frelinger

http://www.w3.org/2001/XMLSchema#string

Lydia M Roberts

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Tularemia

Live attenuated Francisella novicida vaccine protects against Francisella tularensis pulmonary challenge in rats and non-human primates

The involvement of IL-17A in the murine response to sub-lethal inhalational infection with Francisella tularensis

Biological warfare. A historical perspective

Signatures of T cells as correlates of immunity to Francisella tularensis

Live attenuated tularemia vaccines: recent developments and future goals.

Monophosphoryl Lipid A Enhances Efficacy of a Francisella tularensis LVS-Catanionic Nanoparticle Subunit Vaccine against F. tularensis Schu S4 Challenge by Augmenting both Humoral and Cellular Immunity.

Live attenuated mutants of Francisella tularensis protect rabbits against aerosol challenge with a virulent type A strain.

Novel catanionic surfactant vesicle vaccines protect against Francisella tularensis LVS and confer significant partial protection against F. tularensis Schu S4 strain

Role of TLR signaling in Francisella tularensis-LPS-induced, antibody-mediated protection against Francisella tularensis challenge.

P304

115

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FCIMB.2018.00115

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Daniel A Powell

P577

2018-04-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29682484

http://www.w3.org/2001/XMLSchema#string

P921

Añaki

tularemia

P932

5898179

http://www.w3.org/2001/XMLSchema#string